Diagnostics Company Sofie Biosciences Completes $3.7M Financing Round

Sofie Biosciences, a Los Angeles, CA-based diagnostics company developing technologies for PET in vivo molecular imaging, completed a $3.7M financing.

The backers were not disclosed.

The company intends to utilize funds to continue to develop diagnostic imaging agents and scanners.

Led by President & CEO Patrick Phelps and COO Philipp Czernin, Sofie Biosciences aims to increase the adoption and application diversity of Positron Emission Tomography (PET), a non-invasive, translational imaging technology that quantitatively and safely measures the biology of disease.

FinSMEs

14/06/2016